EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Melatonin decreases human adipose tissue insulin sensitivity

Carolina Zambrano, Mireia Tena Garitaonaindia, Diego Salmerón, Fernando Pérez-Sanz, Cynthia Tchio, María Cecilia Picinato, Fermín Sánchez de Medina, Juan Luján, Frank A J L Scheer, Richa Saxena, Olga Martínez-Augustin, Marta Garaulet

Journal of Pineal Research · 2024-08 · 76 (5)

DOI: 10.1111/jpi.12965 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Pineal Research, online erschienen am 11.06.2024. Verfasst von Carolina Zambrano und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physiology, Regional Campus of International Excellence, University of Murcia, Murcia, Spain. Hauptthemen laut MEDLINE: Melatonin, Insulin Resistance. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: PI21/00952, PID2020-120140RB-I00, NHLBI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Melatonin is a pineal hormone that modulates the circadian system and exerts soporific and phase‐shifting effects. It is also involved in many other physiological processes, such as those implicated in cardiovascular, endocrine, immune, and metabolic functions. However, the role of melatonin in glucose metabolism remains contradictory, and its action on human adipose tissue (AT) explants has not been demonstrated. We aimed to assess whether melatonin (a pharmacological dose) influences insulin sensitivity in human AT. This will help better understand melatonin administration's effect on glucose metabolism. Abdominal AT (subcutaneous and visceral) biopsies were obtained from 19 participants with severe obesity (age: 42.84 ± 12.48 years; body mass index: 43.14 ± 8.26 kg/m 2 ) who underwent a laparoscopic gastric bypass. AT biopsies were exposed to four different treatments: control (C), insulin alone (I) (10 nM), melatonin alone (M) (5000 pg/mL), and insulin plus melatonin combined (I + M). All four conditions were repeated in both subcutaneous and visceral AT, and all were performed in the morning at 8 a.m. ( n = 19) and the evening at 8 p.m. (in a subsample of n = 12). We used western blot analysis to determine insulin signaling (using the pAKT/tAKT ratio). Furthermore, RNAseq analyses were performed to better understand the metabolic pathways involved in the effect of melatonin on insulin signaling. As expected, insulin treatment (I) increased the pAKT/tAKT ratio compared with control ( p < .0001). Furthermore, the addition of melatonin (I + M) resulted in a decrease in insulin signaling as compared with insulin alone (I); this effect was significant only during the evening time (not in the morning time). Further, RNAseq analyses in visceral AT during the evening condition (at 8 p.m.) showed that melatonin resulted in a prompt transcriptome response (around 1 h after melatonin addition), particularly by downregulating the insulin signaling pathway. Our results show that melatonin reduces insulin sensitivity in human AT during the evening. These results may partly explain the previous studies showing a decrease in glucose tolerance after oral melatonin administration in the evening or when eating late when endogenous melatonin is present.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MelatoninInsulin ResistanceHumansAdultMaleFemaleMiddle AgedInsulinAdipose Tissue

Stichwörter der Autor:innen

adipose tissueexplantsinsulin sensitivitymelatoninobesity

Substanzen

MelatoninInsulin

Autor:innen und Institutionen

  • Department of Physiology, Regional Campus of International Excellence, University of Murcia, Murcia, Spain.
  • Research Biomedical Institute of Murcia (IMIB)-Arrixaca, Murcia, Spain.
  • Department of Biochemistry and Molecular Biology II, Centro de Investigación Biomédica en Red en Enfermedades Hepáticas y Digestivas (CIBERehd), Ibs Granada, Instituto de Nutrición y Tecnología de los Alimentos (INYTA)…
  • Health and Social Sciences Department, University of Murcia, Murcia, Spain.
  • Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, Spain.
  • Center for Genomic Medicine, Massachusetts General Hospital, Cambridge, Massachusetts, USA.

Förderung

  • PI21/00952
  • PID2020-120140RB-I00
  • NHLBI NIH HHS
  • PID2020-112768RB-I00
  • NIDDK NIH HHS
  • Rank NHLBI R01HL140574
  • A-AGR-468-UGR20 and P20-00695, CTS235, CTS164
  • NIDDK R01DK105072

Zitieren

APA

Zambrano, C., Garitaonaindia, M. T., Salmerón, D., Pérez-Sanz, F., Tchio, C., Picinato, M. C., de Medina, F. S., Luján, J., Scheer, F. A. J. L., Saxena, R., Martínez-Augustin, O., & Garaulet, M. (2024). Melatonin decreases human adipose tissue insulin sensitivity. Journal of Pineal Research, 76(5). https://doi.org/10.1111/jpi.12965

Vancouver

Zambrano C, Garitaonaindia MT, Salmerón D, Pérez-Sanz F, Tchio C, Picinato MC, et al. Melatonin decreases human adipose tissue insulin sensitivity. Journal of Pineal Research. 2024;76(5). doi:10.1111/jpi.12965

BibTeX
@article{Zambrano2024,
  author = {Zambrano, Carolina and Garitaonaindia, Mireia Tena and Salmerón, Diego and Pérez-Sanz, Fernando and Tchio, Cynthia and Picinato, María Cecilia and de Medina, Fermín Sánchez and Luján, Juan and Scheer, Frank A J L and Saxena, Richa and Martínez-Augustin, Olga and Garaulet, Marta},
  title = {Melatonin decreases human adipose tissue insulin sensitivity},
  journal = {Journal of Pineal Research},
  year = {2024},
  volume = {76},
  number = {5},
  doi = {10.1111/jpi.12965}
}
Kostenlos starten →